ECMOHO Limited and Harbin Pharmaceutical Group Announce Joint Launch of New Iron Supplement Product
17 Mayo 2021 - 5:22AM
ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a
leading integrated solutions provider in the health and wellness
market in China, announced today that on May 10, 2021, a new
product, Puxue Oral Liquid, which is a supplement intended for use
by children aged between one and 17, adults, pregnant women, and
nursing mothers who suffer from iron and vitamin B12 deficiencies,
is jointly launched by the Company and Harbin Pharmaceutical Group
Co., Ltd. (“HPGC”). ECMOHO is primarily responsible for the
packaging design and sales distribution of the new product.
Iron and vitamin B12 deficiencies may lead to anemia, which may
cause a series of health problems, including asthenia and
exercise-induced asthma, as well as chronic brain hypoxia, which
affects normal cognitive ability, and may negatively impact the
body’s immune system. This new oral liquid supplement is designed
to ameliorate iron and B12 deficiencies-induced health problems
faced by many Chinese consumers.
HPGC is a large medical health enterprise based in China, with
six business segments which mainly cover antibiotics, OTC drugs and
health products, traditional and modern Chinese medicine,
biomedicine, animal vaccines and pharmaceutical business. HPGC
possesses industry-leading independent R&D capabilities in
medicine and health products. It is also the single largest
shareholder of GNC, a well-known healthcare product retailer in the
United States.
Ms. Zoe Wang, Chairman and Chief Executive Officer of ECMOHO,
stated: “In collaboration with HPGC, we launched this high-quality
and effective iron and vitamin B12 supplement product to address
the significant needs of people who suffer from symptoms caused by
iron deficiency, and support their nutrition and health needs. We
are pleased to partner with such a prominent company as HPGC to
launch the Puxue Oral Liquid product. Our strategic cooperation
demonstrates our mutual commitment to introducing new health
products to address unmet needs and take advantage of the
significant market opportunities in China’s health and wellness
market.”
About ECMOHO Ltd.
ECMOHO is a leading integrated solution provider in the health
and wellness market in China. The Company acts as the bridge
between brand owners and Chinese consumers by marketing and
distributing health supplements and food, mother and child care
products, personal care products, household healthcare equipment
and other health and wellness products. Through over ten years of
operation, ECMOHO has built an ecosystem where Chinese consumers
are provided with customized health and wellness solutions that
include quality products and trustworthy content.
For more information, please visit http://ir.ecmoho.com/.
Safe Harbor Statements
This news release contains forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended, and as defined in the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be
identified by terminology such as “will,” “expects,” “anticipates,”
“future,” “intends,” “plans,” “believes,” “estimates,” “target,”
“going forward,” “outlook” and similar statements. Any statements
that are not historical facts are forward-looking statements. Such
statements are based upon management’s current expectations and
current market and operating conditions, and relate to events that
involve known or unknown risks, uncertainties and other factors,
such as the significant volatility and disruption caused by the
COVID-19 pandemic, the Company’s expected growth of the online
retail industry in China, the Company’s expectations regarding
demand for and market acceptance of its products and services, the
Company’s expectations regarding its relationships with its brand
partners and e-commerce channels, and the level of consumer
economic activity in China, all of which are difficult to predict
and many of which are beyond the Company’s control, which may cause
the Company’s actual results, performance or achievements to differ
materially from those in the forward-looking statements. Further
information regarding these and other risks, uncertainties or
factors is included in the Company’s filings with the U.S.
Securities and Exchange Commission. The Company does not undertake
any obligation to update any forward-looking statement as a result
of new information, future events or otherwise, except as required
under applicable law.
For investor and media inquiries, please contact:
ECMOHO Limited
Investor Relations
Email: ir@ecmoho.com
Investor Relations Agency Contact:
Skyline Corporate Communications Group, LLCLisa
Gray, Senior Account
ManagerOne Rockefeller Plaza, 11th FloorNew York, NY 10020Office: (646) 893-5835Email: lisa@skylineccg.com
ECMOHO (NASDAQ:MOHO)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
ECMOHO (NASDAQ:MOHO)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024